logo

In The Spotlight

Share

novus-052318.jpg Shares of Novus Therapeutics (NVUS) are up an impressive 47% so far this month while the iShares Nasdaq Biotechnology Index (ETF)(IBB) is up a mere 3% for the same period.

inspire-system-051618.jpg Shares of Inspire Medical Systems Inc. (INSP) have climbed 32% since the Company went public this month.

evolus-may9.jpg Shares of Evolus Inc. (EOLS) are up an impressive 38% so far this month while the iShares Nasdaq Biotechnology Index (ETF)(IBB) is down 1% for the same period.

eloxx-050318.jpg Shares of Eloxx Pharmaceuticals Inc. (ELOX) have gained an impressive 65% so far this year while the iShares NASDAQ Biotechnology Index (ETF)(IBB) is down 4.5% during the same period.

siga-spotlight-041918.jpg Shares of SIGA Technologies Inc. (SIGA) are up nearly 30 percent year-to-date while the iShares NASDAQ Biotechnology Index (ETF)(IBB) has returned a mere 0.5% during the same period.

apellis-spotlight-041218.jpg Shares of Apellis Pharmaceuticals Inc. (APLS), which touched a new high of $29.34 on Wednesday, are up nearly 26% year-to-date while the iShares NASDAQ Biotechnology Index (ETF)(IBB) is down 1.3% for the same period.

urogenpharma-040518.jpg Shares of Urogen Pharma Ltd. (URGN) are up nearly 70% year-to-date while the iShares Nasdaq Biotechnology ETF (IBB) index has lost 0.8% during the same period.

zyme-spotlight-032918.jpg Shares of Zymeworks Inc. (ZYME) (ZYME.TO) have climbed 48% year-to-date while the iShares NASDAQ Biotechnology Index (ETF)(IBB) is down 1.4% for the same period.

g10therapeutics-032118.jpg Shares of G1 Therapeutics Inc. (GTHX) have returned an impressive 103% year-to-date while the iShares NASDAQ Biotechnology Index (ETF)(IBB) is up a paltry 2.8% during the same period.

AvenueTherapeutics-031518.jpg Shares of Avenue Therapeutics Inc. (ATXI) have returned an impressive 48% while the iShares Nasdaq Biotechnology ETF (IBB) is up just 6% during the same period.

Biohavenpharma-030718.jpg Shares of Biohaven Pharmaceutical Holding Co. Ltd. (BHVN) are up 14% year-to-date compared to 4% gain by the iShares NASDAQ Biotechnology Index (ETF)(IBB).

Armobio-Pancreas-030118.jpg Since its public debut in January of this year, ARMO Biosciences Inc. (ARMO) has gained more than 50% in sharp contrast to the iShares NASDAQ Biotechnology Index's (ETF)(IBB) measly return of 1.23%.

InflaRx-USD-022218.jpg Shares of Inflarx NV (IFRX) are up more than 50% year-to-date while the iShares NASDAQ Biotechnology Index (ETF) has gained only 2% during the same period.

Follow RTT